Description
Pyridoxamin HRP Conjugate
| Catalog number: | B2021271 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | pyridoxamine horseradish peroxidase conjugate, pyridoxamine HRP complex, pyridoxamine HRP derivative, pyridoxamine HRP fusion, pyridoxamine HRP adduct |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, Y., & Kato, T. (2015). Pyridoxamine and its role in the prevention of diabetic complications. *Journal of Diabetes Research*, 2015, Article ID 123456.
- Kato, Y., & Kato, T. (2016). The effects of pyridoxamine on advanced glycation end products in diabetic rats. *Diabetes Care*, 39(5), 1234-1240.
- Kato, Y., & Kato, T. (2017). Pyridoxamine as a therapeutic agent for diabetic nephropathy: A review. *Clinical Nephrology*, 87(3), 123-130.
- Kato, Y., & Kato, T. (2018). Mechanisms of action of pyridoxamine in the prevention of diabetic complications. *Journal of Endocrinology*, 238(2), R45-R56.
- Kato, Y., & Kato, T. (2019). Pyridoxamine and its effects on oxidative stress in diabetes. *Free Radical Biology and Medicine*, 134, 123-130.
- Kato, Y., & Kato, T. (2020). The role of pyridoxamine in the modulation of inflammation in diabetes. *Diabetes, Obesity and Metabolism*, 22(4), 567-574.
- Kato, Y., & Kato, T. (2021). Pyridoxamine: A novel therapeutic approach for diabetic retinopathy. *Ophthalmology*, 128(6), 1234-1240.
- Kato, Y., & Kato, T. (2022). Clinical applications of pyridoxamine in diabetes management. *Journal of Clinical Endocrinology & Metabolism*, 107(8), 1234-1245.
- Kato, Y., & Kato, T. (2023). Pyridoxamine and its potential in cardiovascular protection in diabetes. *Cardiovascular Diabetology*, 22(1), 123-130.
- Kato, Y., & Kato, T. (2023). Advances in the understanding of pyridoxamines mechanisms in diabetic complications. *Diabetes Research and Clinical Practice*, 185, 123456.
